Moreover, tumors highly express CXCL12 (SDF1α), the ligand for CXCR4 (CD184), a homeostatic chemokine receptor found to be mostly involved in attracting immune cells within the tumor tissue, contributing to an immunosuppressive milieu (14). Here, CXCL12 is linked to neoplasm.